查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1822367

2032 年医疗保健市场 3D 列印预测：按材料、技术、应用、最终用户和地区进行的全球分析

3D Printing in Healthcare Market Forecasts to 2032 - Global Analysis By Material (Polymers, Ceramics, Metals, Hydrogels and Bioinks, and Biocompatible Materials), Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球医疗保健 3D 列印市场预计在 2025 年达到 19.9 亿美元，到 2032 年将达到 71.5 亿美元，预测期内的复合年增长率为 20.03%。

医疗保健领域的 3D 列印是指利用积层製造来创建患者专属的医疗产品、模型和设备。它能够生产客製化的植入、假体、用于手术规划的解剖模型，甚至生物列印的组织和器官。 3D 列印凭藉其精准度、个人化和更​​快的原型製作製作能力，正在改变医疗保健服务，改善疗效，降低成本，同时推动个人化医疗和再生医学解决方案的创新。

据 Stratasys 称，J5 Digital Anatomy 旨在改善患者的治疗效果、提高手术效率并加快解剖产品的上市时间。

个人化医疗解决方案的需求不断增长

在医疗保健领域，针对特定患者的治疗需求激增，推动了 3D 列印技术的普及。客製化植入、假体和解剖模型能够实现更精准的手术规划并改善临床疗效。生物列印和组织工程的进步正在拓展个人化医疗的范围。医院正在整合人工智慧主导的设计平台，以提供根据每位患者的特定解剖结构量身定制的设备。这种转变在肿瘤科、整形外科和重组外科领域尤其明显。随着精准医疗的发展势头强劲，3D 列印正成为下一代治疗策略的核心组成部分。

可用于医疗级列印的材料有限

医用级聚合物和金属的监管标准非常严格，需要进行大量的检验和测试。生物可吸收复合材料和抗菌丝等新技术前景广阔，但尚未广泛商业化。小型製造商在采购核准材料方面面临挑战，这限制了其创新和市场准入。特种材料供应链缺乏标准化，进一步加剧了生产扩充性的复杂性。在更广泛的材料组合已开发和认证之前，临床应用的成长可能仍将受到限制。

扩大牙科和整形外科领域的应用

高精度製造患者专用组件的能力正在彻底改变手术工作流程。数位化牙科利用口内扫描器和 CAD/CAM 系统来简化牙冠和牙桥的製作。骨科医生正在使用列印的骨支架和人工关节来增强修復效果和贴合度。列印钛和 PEEK植入的监管审批正在加速这些领域的应用。随着材料科学和成像技术的发展，这些领域很可能将继续引领临床整合的发展。

数位设计檔案的网路安全风险

医疗保健製造业的数位化带来了设计文件完整性和资料安全性方面的漏洞。未授权存取患者特定的 CAD 模型可能会危及机密性和装置准确性。医院和製造商越来越多地采用区块链和加密通讯协定来保护数位资产。针对云端基础设计储存库的网路攻击对生产连续性和法规遵循构成风险。物联网印表机与远端监控系统的整合进一步增加了网路威胁的风险。如果没有稳固的网路安全框架，3D 列印医疗设备的可靠性和安全性可能会受到损害。

COVID-19的影响

疫情扰乱了全球供应链，推迟了择期手术，暂时减缓了3D列印在临床环境中的应用。然而，这场危机凸显了积层製造在生产拭子和人工呼吸器零件等紧急医疗用品方面的弹性。监管机构推出了列印个人防护装备和诊断工具的快速核准，提升了市场认知度。后疫情时代，策略重点强调弹性、自动化和本地生产，以减少对传统供应链的依赖。疫情最终激发了创新，并拓展了3D列印在医疗保健领域的角色。

预测期内聚合物领域预计将实现最大幅度成长

预计聚合物领域因其多功能性和成本效益将在预测期内占据最大的市场份额。 PLA、ABS 和 PEEK 等生物相容性聚合物广泛应用于义肢、手术模型和牙科应用。聚合物化学的不断进步使其具有更好的机械性能和灭菌兼容性。医院青睐聚合物基器械，因为它们重量轻且易于自订。新兴趋势包括抗菌涂层和专为短期植入定制的可生物降解配方。随着材料创新的不断推进，聚合物很可能仍将是医疗 3D 列印解决方案的支柱。

医院和手术中心部门预计将在预测期内实现最高的复合年增长率

预计医院和外科中心细分市场将在预测期内呈现最高成长率。这些机构越来越多地使用印刷的解剖模型进行术前规划和病患教育。人工智慧设计软体的整合使得手术器械和植入的快速原型製作成为可能。个人化医疗和微创手术的转变正在推动对客製化设备的需求。医院也在投资内部列印实验室，以缩短采购前置作业时间并提高手术效率。随着临床工作流程的发展，3D列印正成为外科创新的核心组成部分。

占比最大的地区：

预计亚太地区将在预测期内占据最大的市场份额，这得益于对医疗基础设施和技术的强劲投资。中国、印度和韩国等国正在扩大其医疗设备的本地製造能力。政府正在透过补贴和官民合作关係关係推动数位医疗和进口替代。在 3D 列印工具的推动下，该地区正在迅速采用人工智慧辅助诊断和机器人手术。全球原始设备製造商和区域参与者之间的策略联盟正在加速技术转移和市场渗透。不断增长的手术量和不断壮大的中阶使亚太地区保持领先地位。

复合年增长率最高的地区：

预计北美在预测期内将呈现最高的复合年增长率，这得益于其强大的研发生态系统和先进技术的早期应用。美国和加拿大在生物列印、智慧植入和人工智慧整合设计平台领域处于领先地位。监管机构正在简化列印医疗设备的核准途径，以促进更快的商业化。医院正在利用物联网和云端基础系统来优化3D列印工作流程和库存管理。该地区受益于成熟的报销框架和对个人化治疗的高需求。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球医疗保健市场3D列印材料

  • 聚合物
  • 陶瓷
  • 金属
  • 水凝胶和生物墨水
  • 生物相容性材料

6. 全球医疗保健市场 3D 列印技术

  • 立体光固成型（SLA）
  • 选择性雷射烧结（SLS）
  • 熔融沈积成型（FDM）
  • 电子束熔炼（EBM）
  • 层压实体製造（LOM）
  • 光聚合
  • 其他技术

7. 全球医疗保健市场3D列印应用状况

  • 医疗植入
    • 整形外科植入
    • 颅颚颜面植入
  • 义肢
    • 义肢
    • 牙科修补
  • 手术器械
    • 定製手术范本
    • 钳子
  • 组织工程与生物列印
    • 器官支架
    • 皮肤和软骨
  • 解剖模型
    • 术前计划
    • 教育用途
  • 外部穿戴装置
    • 助听器
    • 正畸器具
  • 药物输送装置
    • 个人化药物胶囊
    • 微流体系统
  • 其他用途

8. 全球医疗保健市场 3D 列印终端用户分布

  • 医院和外科中心
  • 牙医诊所
  • 学术研究机构
  • 医疗设备製造商
  • 製药和生物技术公司
  • 其他最终用户

9. 全球医疗保健市场3D列印区域分布

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Stratasys Ltd.
  • Prodways Group
  • 3D Systems Inc.
  • Anatomics Pty Ltd
  • Materialise NV
  • CELLINK
  • EOS GmbH
  • Zortrax SA
  • Renishaw PLC
  • SLM Solutions Group AG
  • Organovo Holdings Inc.
  • Arcam AB
  • EnvisionTEC GmbH
  • Nanoscribe GmbH & Co. KG
  • Oxford Performance Materials
Product Code: SMRC31121

According to Stratistics MRC, the Global 3D Printing in Healthcare Market is accounted for $1.99 billion in 2025 and is expected to reach $7.15 billion by 2032 growing at a CAGR of 20.03% during the forecast period. 3D printing in healthcare refers to the use of additive manufacturing technologies to create patient-specific medical products, models, and devices. It enables the production of customized implants, prosthetics, anatomical models for surgical planning, and even bioprinted tissues and organs. By offering precision, personalization, and faster prototyping, 3D printing is transforming healthcare delivery, improving treatment outcomes, and reducing costs while advancing innovations in personalized medicine and regenerative healthcare solutions.

According to Stratasys, J5 Digital Anatomy seeks to improve patient outcomes, increase the efficiency of operating procedures and accelerate the market availability of anatomical products.

Market Dynamics:

Driver:

Growing demand for personalized medical solutions

The healthcare sector is witnessing a surge in demand for patient-specific treatments, driving the adoption of 3D printing technologies. Custom implants, prosthetics, and anatomical models are enabling more precise surgical planning and improved clinical outcomes. Advances in bio-printing and tissue engineering are expanding the scope of personalized medicine. Hospitals are integrating AI-driven design platforms to tailor devices to individual patient anatomies. This shift is particularly prominent in oncology, orthopedics, and reconstructive surgery. As precision medicine gains momentum, 3D printing is becoming central to next-generation therapeutic strategies.

Restraint:

Limited material availability for medical-grade printing

Regulatory standards for medical-grade polymers and metals are stringent, requiring extensive validation and testing. Emerging technologies like bioresorbable composites and antimicrobial filaments are promising but not yet widely commercialized. Smaller manufacturers face challenges in sourcing approved materials, limiting innovation and market entry. The lack of standardized supply chains for specialty materials further complicates production scalability. Until broader material portfolios are developed and certified, growth in clinical applications will remain constrained.

Opportunity:

Increasing adoption in dental and orthopedic sectors

The ability to produce patient-specific components with high precision is transforming procedural workflows. Digital dentistry is leveraging intraoral scanners and CAD/CAM systems to streamline crown and bridge fabrication. Orthopedic surgeons are using printed bone scaffolds and joint replacements to enhance recovery and fit. Regulatory approvals for printed titanium and PEEK implants are accelerating adoption in these segments. As material science and imaging technologies evolve, these sectors will continue to lead in clinical integration.

Threat:

Cybersecurity risks in digital design files

The digitization of healthcare manufacturing introduces vulnerabilities in design file integrity and data security. Unauthorized access to patient-specific CAD models can compromise confidentiality and device accuracy. Hospitals and manufacturers are increasingly deploying blockchain and encryption protocols to safeguard digital assets. Cyberattacks targeting cloud-based design repositories pose risks to production continuity and regulatory compliance. The integration of IoT-enabled printers and remote monitoring systems adds further exposure to cyber threats. Without robust cybersecurity frameworks, the reliability and safety of 3D-printed medical devices may be jeopardized.

Covid-19 Impact

The pandemic disrupted global supply chains and delayed elective procedures, temporarily slowing the adoption of 3D printing in clinical settings. However, the crisis also highlighted the flexibility of additive manufacturing in producing emergency medical supplies like swabs and ventilator components. Regulatory bodies introduced fast-track approvals for printed PPE and diagnostic tools, boosting market visibility. Post-COVID strategies now emphasize resilience, automation, and localized manufacturing to reduce dependency on traditional supply chains. The pandemic ultimately catalyzed innovation and broadened the role of 3D printing in healthcare preparedness.

The polymers segment is expected to be the largest during the forecast period

The polymers segment is expected to account for the largest market share during the forecast period, due to its versatility and cost-effectiveness. Biocompatible polymers such as PLA, ABS, and PEEK are widely used in prosthetics, surgical models, and dental applications. Continuous advancements in polymer chemistry are enabling better mechanical properties and sterilization compatibility. Hospitals prefer polymer-based devices for their lightweight nature and ease of customization. Emerging trends include antimicrobial coatings and biodegradable formulations tailored for short-term implants. As material innovation progresses, polymers will remain the backbone of medical 3D printing solutions.

The hospitals & surgical centres segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals & surgical centres segment is predicted to witness the highest growth rate. These facilities are increasingly using printed anatomical models for preoperative planning and patient education. Integration of AI-powered design software is enabling rapid prototyping of surgical tools and implants. The shift toward personalized care and minimally invasive procedures is driving demand for custom devices. Hospitals are also investing in in-house printing labs to reduce procurement lead times and enhance procedural efficiency. As clinical workflows evolve, 3D printing is becoming a core component of surgical innovation.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by robust investments in medical infrastructure and technology. Countries like China, India, and South Korea are expanding local manufacturing capabilities for medical devices. Government initiatives are promoting digital healthcare and import substitution through subsidies and public-private partnerships. The region is witnessing rapid adoption of AI-assisted diagnostics and robotic surgery, supported by 3D-printed tools. Strategic collaborations between global OEMs and regional players are accelerating technology transfer and market penetration. With rising surgical volumes and a growing middle class, Asia Pacific is poised for sustained leadership.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by strong R&D ecosystems and early adoption of advanced technologies. The U.S. and Canada are pioneering innovations in bioprinting, smart implants, and AI-integrated design platforms. Regulatory agencies are streamlining approval pathways for printed medical devices, encouraging faster commercialization. Hospitals are leveraging IoT and cloud-based systems to optimize 3D printing workflows and inventory management. The region benefits from a mature reimbursement framework and high demand for personalized treatments.

Key players in the market

Some of the key players profiled in the 3D Printing in Healthcare Market include Stratasys Ltd., Prodways Group, 3D Systems Inc., Anatomics Pty Ltd, Materialise NV, CELLINK, EOS GmbH, Zortrax S.A., Renishaw PLC, SLM Solutions Group AG, Organovo Holdings Inc., Arcam AB, EnvisionTEC GmbH, Nanoscribe GmbH & Co. KG, and Oxford Performance Materials.

Key Developments:

In July 2025, Stratasys Ltd. announced the commercial launch of P3(TM) Silicone 25A, a high-performance material developed through a strategic collaboration with Shin-Etsu, a global leader in silicone science. Designed exclusively for the Stratasys Origin(R) DLP platform, this general-purpose silicone enables production of flexible parts that match the performance of traditionally molded silicone.

In October 2024, Prodways introduces the DENTAL PRO Series, a cutting-edge range of 3D printers designed specifically for the dental industry, aiming to transform the workflow of dental laboratories by enhancing productivity, precision, and versatility.

Materials Covered:

  • Polymers
  • Ceramics
  • Metals
  • Hydrogels and Bioinks
  • Biocompatible Materials

Technologies Covered:

  • Stereolithography (SLA)
  • Selective Laser Sintering (SLS)
  • Fused Deposition Modeling (FDM)
  • Electron Beam Melting (EBM)
  • Laminated Object Manufacturing (LOM)
  • Photopolymerization
  • Other Technologies

Applications Covered:

  • Medical Implants
  • Prosthetics
  • Surgical Instruments
  • Tissue Engineering & Bioprinting
  • Anatomical Models
  • External Wearable Devices
  • Drug Delivery Devices
  • Other Applications

End Users Covered:

  • Hospitals & Surgical Centers
  • Dental Clinics
  • Academic & Research Institutions
  • Medical Device Manufacturers
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global 3D Printing in Healthcare Market, By Material

  • 5.1 Introduction
  • 5.2 Polymers
  • 5.3 Ceramics
  • 5.4 Metals
  • 5.5 Hydrogels and Bioinks
  • 5.6 Biocompatible Materials

6 Global 3D Printing in Healthcare Market, By Technology

  • 6.1 Introduction
  • 6.2 Stereolithography (SLA)
  • 6.3 Selective Laser Sintering (SLS)
  • 6.4 Fused Deposition Modeling (FDM)
  • 6.5 Electron Beam Melting (EBM)
  • 6.6 Laminated Object Manufacturing (LOM)
  • 6.7 Photopolymerization
  • 6.8 Other Technologies

7 Global 3D Printing in Healthcare Market, By Application

  • 7.1 Introduction
  • 7.2 Medical Implants
    • 7.2.1 Orthopedic Implants
    • 7.2.2 Cranial and Maxillofacial Implants
  • 7.3 Prosthetics
    • 7.3.1 Limb Prosthetics
    • 7.3.2 Dental Prosthetics
  • 7.4 Surgical Instruments
    • 7.4.1 Custom Surgical Guides
    • 7.4.2 Forceps
  • 7.5 Tissue Engineering & Bioprinting
    • 7.5.1 Organ Scaffolds
    • 7.5.2 Skin and Cartilage
  • 7.6 Anatomical Models
    • 7.6.1 Pre-surgical Planning
    • 7.6.2 Educational Use
  • 7.7 External Wearable Devices
    • 7.7.1 Hearing Aids
    • 7.7.2 Orthotic Devices
  • 7.8 Drug Delivery Devices
    • 7.8.1 Personalized Drug Capsules
    • 7.8.2 Microfluidic Systems
  • 7.9 Other Applications

8 Global 3D Printing in Healthcare Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals & Surgical Centers
  • 8.3 Dental Clinics
  • 8.4 Academic & Research Institutions
  • 8.5 Medical Device Manufacturers
  • 8.6 Pharmaceutical & Biotechnology Companies
  • 8.7 Other End Users

9 Global 3D Printing in Healthcare Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Stratasys Ltd.
  • 11.2 Prodways Group
  • 11.3 3D Systems Inc.
  • 11.4 Anatomics Pty Ltd
  • 11.5 Materialise NV
  • 11.6 CELLINK
  • 11.7 EOS GmbH
  • 11.8 Zortrax S.A.
  • 11.9 Renishaw PLC
  • 11.10 SLM Solutions Group AG
  • 11.11 Organovo Holdings Inc.
  • 11.12 Arcam AB
  • 11.13 EnvisionTEC GmbH
  • 11.14 Nanoscribe GmbH & Co. KG
  • 11.15 Oxford Performance Materials

List of Tables

  • Table 1 Global 3D Printing in Healthcare Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global 3D Printing in Healthcare Market Outlook, By Material (2024-2032) ($MN)
  • Table 3 Global 3D Printing in Healthcare Market Outlook, By Polymers (2024-2032) ($MN)
  • Table 4 Global 3D Printing in Healthcare Market Outlook, By Ceramics (2024-2032) ($MN)
  • Table 5 Global 3D Printing in Healthcare Market Outlook, By Metals (2024-2032) ($MN)
  • Table 6 Global 3D Printing in Healthcare Market Outlook, By Hydrogels and Bioinks (2024-2032) ($MN)
  • Table 7 Global 3D Printing in Healthcare Market Outlook, By Biocompatible Materials (2024-2032) ($MN)
  • Table 8 Global 3D Printing in Healthcare Market Outlook, By Technology (2024-2032) ($MN)
  • Table 9 Global 3D Printing in Healthcare Market Outlook, By Stereolithography (SLA) (2024-2032) ($MN)
  • Table 10 Global 3D Printing in Healthcare Market Outlook, By Selective Laser Sintering (SLS) (2024-2032) ($MN)
  • Table 11 Global 3D Printing in Healthcare Market Outlook, By Fused Deposition Modeling (FDM) (2024-2032) ($MN)
  • Table 12 Global 3D Printing in Healthcare Market Outlook, By Electron Beam Melting (EBM) (2024-2032) ($MN)
  • Table 13 Global 3D Printing in Healthcare Market Outlook, By Laminated Object Manufacturing (LOM) (2024-2032) ($MN)
  • Table 14 Global 3D Printing in Healthcare Market Outlook, By Photopolymerization (2024-2032) ($MN)
  • Table 15 Global 3D Printing in Healthcare Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 16 Global 3D Printing in Healthcare Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global 3D Printing in Healthcare Market Outlook, By Medical Implants (2024-2032) ($MN)
  • Table 18 Global 3D Printing in Healthcare Market Outlook, By Orthopedic Implants (2024-2032) ($MN)
  • Table 19 Global 3D Printing in Healthcare Market Outlook, By Cranial and Maxillofacial Implants (2024-2032) ($MN)
  • Table 20 Global 3D Printing in Healthcare Market Outlook, By Prosthetics (2024-2032) ($MN)
  • Table 21 Global 3D Printing in Healthcare Market Outlook, By Limb Prosthetics (2024-2032) ($MN)
  • Table 22 Global 3D Printing in Healthcare Market Outlook, By Dental Prosthetics (2024-2032) ($MN)
  • Table 23 Global 3D Printing in Healthcare Market Outlook, By Surgical Instruments (2024-2032) ($MN)
  • Table 24 Global 3D Printing in Healthcare Market Outlook, By Custom Surgical Guides (2024-2032) ($MN)
  • Table 25 Global 3D Printing in Healthcare Market Outlook, By Forceps (2024-2032) ($MN)
  • Table 26 Global 3D Printing in Healthcare Market Outlook, By Tissue Engineering & Bioprinting (2024-2032) ($MN)
  • Table 27 Global 3D Printing in Healthcare Market Outlook, By Organ Scaffolds (2024-2032) ($MN)
  • Table 28 Global 3D Printing in Healthcare Market Outlook, By Skin and Cartilage (2024-2032) ($MN)
  • Table 29 Global 3D Printing in Healthcare Market Outlook, By Anatomical Models (2024-2032) ($MN)
  • Table 30 Global 3D Printing in Healthcare Market Outlook, By Pre-surgical Planning (2024-2032) ($MN)
  • Table 31 Global 3D Printing in Healthcare Market Outlook, By Educational Use (2024-2032) ($MN)
  • Table 32 Global 3D Printing in Healthcare Market Outlook, By External Wearable Devices (2024-2032) ($MN)
  • Table 33 Global 3D Printing in Healthcare Market Outlook, By Hearing Aids (2024-2032) ($MN)
  • Table 34 Global 3D Printing in Healthcare Market Outlook, By Orthotic Devices (2024-2032) ($MN)
  • Table 35 Global 3D Printing in Healthcare Market Outlook, By Drug Delivery Devices (2024-2032) ($MN)
  • Table 36 Global 3D Printing in Healthcare Market Outlook, By Personalized Drug Capsules (2024-2032) ($MN)
  • Table 37 Global 3D Printing in Healthcare Market Outlook, By Microfluidic Systems (2024-2032) ($MN)
  • Table 38 Global 3D Printing in Healthcare Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 39 Global 3D Printing in Healthcare Market Outlook, By End User (2024-2032) ($MN)
  • Table 40 Global 3D Printing in Healthcare Market Outlook, By Hospitals & Surgical Centers (2024-2032) ($MN)
  • Table 41 Global 3D Printing in Healthcare Market Outlook, By Dental Clinics (2024-2032) ($MN)
  • Table 42 Global 3D Printing in Healthcare Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
  • Table 43 Global 3D Printing in Healthcare Market Outlook, By Medical Device Manufacturers (2024-2032) ($MN)
  • Table 44 Global 3D Printing in Healthcare Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 45 Global 3D Printing in Healthcare Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.